학술논문
Application of Large Community-Based Cohort Study to Further Define Benefit-Risk Profile of Newly Approved Product - A Study of Bevacizumab (Avastin, BV): 348.
Document Type
Academic Journal
Author
Source
Pharmacoepidemiology and Drug Safety. Jul 01, 2007 16 Supp 2:S165-S165
Subject
Language
English
ISSN
1053-8569